Navigation Links
Colleen Goggins, Worldwide Chairman, Consumer Group Plans Retirement From Johnson & Johnson in Early 2011
Date:9/16/2010

NEW BRUNSWICK, N.J., Sept. 16 /PRNewswire-FirstCall/ -- Johnson & Johnson (NYSE: JNJ) said today that Colleen Goggins, 56, Worldwide Chairman, Consumer Group, has announced her retirement from the Company effective March 1, 2011, after a successful and distinguished career spanning almost 30 years.

William C. Weldon, Chairman and CEO, said, "Throughout her tenure, Colleen has demonstrated our commitment to our consumers and our people, and has made major contributions to our success.  We thank Colleen for her dedication and extraordinary service, and wish her all the best in the years to come."

Ms. Goggins joined Johnson & Johnson in 1981, working in various assignments of increasing responsibility.  She became President of Johnson & Johnson Canada in 1992; President, Personal Products Company, U.S. in 1994; and President, Johnson & Johnson Consumer Companies Inc. in 1995.  She was promoted to Company Group Chairman in 1998.  Colleen assumed her current position as a member of the Executive Committee in June 2001.

Mr. Weldon added: "Colleen is among the group of executives that have led the effort to formulate and implement the remediation plan regarding the quality issues at McNeil.  In light of Colleen's decision to retire, I am pleased that we have a clear remediation plan in place and we will work together to ensure a smooth transition of her responsibilities. We will make a timely announcement of succession plans for this critical position for the Company."


'/>"/>
SOURCE Johnson & Johnson
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Reportlinker Adds Portable and Transport Ventilator Market Shares, Strategies, and Forecasts, Worldwide, 2010 to 2016
2. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
3. TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System
4. Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
5. SCOLR Pharma, Inc. Enters into Worldwide Licensing Agreement with RedHill Biopharma Ltd.
6. Eye-Fi Expands Hotspot Access Service Worldwide
7. Orbitz Worldwide, Inc. to Host First Quarter 2010 Earnings Call on May 5
8. Best Practice Adopted Worldwide From Norway to Australia
9. Elekta VMAT Radiation Therapy Rapidly Gaining Users Worldwide as Technique Evolves
10. Cephalon Executive Vice President of Worldwide Pharmaceutical Operations Robert Roche to Resign Position
11. Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... 4, 2017 OBP Medical , ... medical devices, today announced regulatory approval from ... (or Agência Nacional de Vigilância Sanitária (ANVISA)) to ... surgical retractor with integrated LED light source and ... and exposure of a tissue pocket or cavity ...
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... system that we intend to develop to enable prevention of a major side ... severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA ...
Breaking Medicine News(10 mins):